Aug 14 (Reuters) - The following are the top stories in

the Financial Times. Reuters has not verified these stories and

does not vouch for their accuracy.

Headlines

- AstraZeneca ( AZN ) hits 200 billion STG valuation

- Hipgnosis sues Barry Manilow over bonus payments

- UK housebuilder Bellway ( BLWYF ) walks away from Crest Nicholson

takeover bid

- Brussels slaps down Thierry Breton over 'harmful content'

letter to Elon Musk

Overview

- AstraZeneca ( AZN ) has become the only current UK-listed

company to reach a 200 billion pound valuation, in a vindication

of the company's bet on developing a leading portfolio of cancer

drugs.

- Hipgnosis Songs Fund is suing Barry Manilow

over bonus payments tied to its purchase of the American

singer's back catalogue.

- British homebuilder Bellway ( BLWYF ) has unexpectedly

dropped its 720 million pound ($925.70 million) bid to buy

smaller peer Crest Nicholson, sending Crest's shares

almost 20% lower on Tuesday.

- Brussels has accused its internal market commissioner of

going rogue by sending a letter to Elon Musk threatening

punishment if content posted on social media site X was found to

place EU citizens at risk of "serious harm".

($1 = 0.7778 pounds)

(Compiled by Bengaluru newsroom)